Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Estella Matutes & Aaron Polliack. (2019) CLL and CML sometimes meet and circulate together. Leukemia & Lymphoma 60:6, pages 1352-1353.
Read now
Read now
Prajwal Boddu, Jamie Gibbons, Jan Burger, Mariela Sivina, Beenu Thakral, Rashmi Kanagal-Shamanna & Alessandra Ferrajoli. (2019) Co-occurrence of chronic myeloid leukemia with chronic lymphocytic leukemia: a report of two cases. Leukemia & Lymphoma 60:6, pages 1568-1571.
Read now
Read now
Matthew Ku, Meaghan Wall, Ruth N. MacKinnon, Carl R. Walkley, Louise E. Purton, Constantine Tam, David Izon, Lynda Campbell, Heung-Chin Cheng & Harshal Nandurkar. (2015) Src family kinases and their role in hematological malignancies. Leukemia & Lymphoma 56:3, pages 577-586.
Read now
Read now
Articles from other publishers (15)
Ying Wang, Ting Bin, Jing Tang, Xiao-Jun Xu, Chao Lin, Bo Lu & Tian-Tian Sun. (2023) Construction of an acute myeloid leukemia prognostic model based on m6A-related efferocytosis-related genes. Frontiers in Immunology 14.
Crossref
Crossref
Robert RoskoskiJr.Jr.. (2018) The role of small molecule Kit protein-tyrosine kinase inhibitors in the treatment of neoplastic disorders. Pharmacological Research 133, pages 35-52.
Crossref
Crossref
Ewa Rupniewska, Rajat Roy, Francesco A. Mauri, Xinxue Liu, Maciej Kaliszczak, Guido Bellezza, Lucio Cagini, Mattia Barbareschi, Stefano Ferrero, Anna M. Tommasi, Eric Aboagye, Michael J. Seckl & Olivier E. Pardo. (2018) Targeting autophagy sensitises lung cancer cells to Src family kinase inhibitors. Oncotarget 9:44, pages 27346-27362.
Crossref
Crossref
Noriyoshi Iriyama, Bo Yuan, Yoshihiro Hatta, Norio Takagi & Masami Takei. (2016) Lyn, a tyrosine kinase closely linked to the differentiation status of primary acute myeloid leukemia blasts, associates with negative regulation of all-trans retinoic acid (ATRA) and dihydroxyvitamin D3 (VD3)-induced HL-60 cells differentiation. Cancer Cell International 16:1.
Crossref
Crossref
Sina OppermannJarkko YlankoYonghong ShiSantosh HariharanChristopher C. OakesPatrick M. BrauerJuan C. Zúñiga-PflückerBrian LeberDavid E. Spaner & David W. Andrews. (2016) High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells. Blood 128:7, pages 934-947.
Crossref
Crossref
Chunling Dong, Bo Li, Zhenyu Li, Sreerama Shetty & Jian Fu. (2016) Dasatinib-loaded albumin nanoparticles possess diminished endothelial cell barrier disruption and retain potent anti-leukemia cell activity. Oncotarget 7:31, pages 49699-49709.
Crossref
Crossref
Marina Dokic, Ivana Urosevic, Ivanka Savic, Borivoj Sekulic, Aleksandar Savic, Ivana Milosevic & Nebojsa Rajic. (2016) A Case of Chronic Lymphocytic Leukaemia Occurring During Treatment of Chronic Myeloid Leukaemia. Indian Journal of Hematology and Blood Transfusion 32:S1, pages 156-158.
Crossref
Crossref
Mio Yano, Toshihiko Imamura, Daisuke Asai, Nobutaka Kiyokawa, Kazuhiko Nakabayashi, Kenji Matsumoto, Takao Deguchi, Yoshiko Hashii, Yu-ko Honda, Daiichiro Hasegawa, Yoji Sasahara, Mutsuo Ishii, Yoshiyuki Kosaka, Koji Kato, Midori Shima, Hiroki Hori, Keiko Yumura-Yagi, Junichi Hara, Megumi Oda, Keizo Horibe, Hitoshi Ichikawa & Atsushi Sato. (2015)
Identification of novel kinase fusion transcripts in paediatric B cell precursor acute lymphoblastic leukaemia with
IKZF1
deletion
. British Journal of Haematology 171:5, pages 813-817.
Crossref
Crossref
R F Dielschneider, W Xiao, J-Y Yoon, E Noh, V Banerji, H Li, A J Marshall, J B Johnston & S B Gibson. (2014) Gefitinib targets ZAP-70-expressing chronic lymphocytic leukemia cells and inhibits B-cell receptor signaling. Cell Death & Disease 5:10, pages e1439-e1439.
Crossref
Crossref
Yiming Zhong, John C. Byrd & Jason A. Dubovsky. (2014) The B-Cell Receptor Pathway: A Critical Component of Healthy and Malignant Immune Biology. Seminars in Hematology 51:3, pages 206-218.
Crossref
Crossref
Veronica Martinez Marignac, Sarah Smith, Nader Toban, Miguel Bazile & Raquel Aloyz. (2013) Resistance to Dasatinib in primary chronic lymphocytic leukemia lymphocytes involves AMPK-mediated energetic re-programming. Oncotarget 4:12, pages 2550-2566.
Crossref
Crossref
Cedric Dos Santos, Tinisha McDonald, Yin Wei Ho, Hongjun Liu, Allen Lin, Stephen J. Forman, Ya-Huei Kuo & Ravi Bhatia. (2013) The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents. Blood 122:11, pages 1900-1913.
Crossref
Crossref
M. Giantin, L. Aresu, A. Aricò, M.E. Gelain, F. Riondato, V. Martini, S. Comazzi & M. Dacasto. (2013) Evaluation of tyrosine-kinase receptor c-KIT (c-KIT) mutations, mRNA and protein expression in canine leukemia: Might c-KIT represent a therapeutic target?. Veterinary Immunology and Immunopathology 152:3-4, pages 325-332.
Crossref
Crossref
Giovanni D'Arena, Marica Gemei, Luigiana Luciano, Fiorella D'Auria, Silvia Deaglio, Teodora Statuto, Gabriella Bianchino, Vitina Grieco, Giovanna Mansueto, Roberto Guariglia, Giuseppe Pietrantuono, Maria Carmen Martorelli, Oreste Villani, Luigi Del Vecchio & Pellegrino Musto. (2012) Chronic Lymphocytic Leukemia After Chronic Myeloid Leukemia in the Same Patient: Two Different Genomic Events and a Common Treatment?. Journal of Clinical Oncology 30:32, pages e327-e330.
Crossref
Crossref
Ju-Yoon Yoon, Rajat Kumar, Raquel Aloyz & James B. Johnston. (2011) Response of concomitant chronic myelogenous leukemia and chronic lymphocytic leukemia to imatinib mesylate. Leukemia Research 35:9, pages e179-e180.
Crossref
Crossref